Limitations of Direct Immunoassays for Measuring Circulating Estradiol Levels in Postmenopausal Women and Men in Epidemiologic Studies

Abstract

Serum estradiol (E₂) serves as an important diagnostic marker in a variety of clinical conditions. In epidemiologic studies, E₂ is commonly used to define the etiologic role of estrogen in hormone-related cancers and chronic conditions. Having an accurate and reliable E₂ assay is of critical importance in these studies, especially when measuring the very low E₂ levels (2 antibodies, direct RIAs without purification steps lack specificity for E₂ and can substantially overestimate E₂ levels. Although direct E₂ RIAs using commercial kits are simpler, less time consuming, and less expensive and require less sample volume than conventional RIAs with preceding purification steps, their lack of sensitivity and specificity makes them invalid for measuring circulating E₂ levels in epidemiologic studies of postmenopausal women or men. Instead, we recommend the use of a well-validated RIA with purification steps to improve sensitivity and specificity and to help achieve the necessary accuracy and reliability needed for epidemiologic studies. Cancer Epidemiol Biomarkers Prev; 19(4); 903–6. ©2010 AACR.